BHI Uri-Control

Manufacturer
MediNatura Inc
Effective date
2023-04-13
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:20:55

Label at a glance#

ProductBHI Uri-Control
Active ingredientAPIS MELLIFERA, SILVER NITRATE, ATROPA BELLADONNA, LYTTA VESICATORIA, CAUSTICUM, EQUISETUM HYEMALE, PETROSELINUM CRISPUM, PULSATILLA VULGARIS, SMILAX ORNATA ROOT, TURPENTINE OIL
Label structure8 sections

Dosage and administration

 Adults: 1-2 tablets 3 times per day or as directed by a health practitioner. Not to exceed 6 tablets per 24 hours. Children under 18, as directed by a health professional. Allow to completely dissolve in the mouth

Label contents#

Full prescribing information#

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. 

Indications:

INDICATIONS & USAGE SECTION

For the temporary relief of minor
urinary pain and urgency.

Warnings:

WARNINGS SECTION

 If pregnant or breast-feeding, ask a
health professional before use. Keep out of reach
of children. If symptoms persist or worsen, a
healthcare provider should be consulted. Do not use
if known sensitivity to BHI Uri-Control or any of its
ingredients exists.

Directions:

DOSAGE & ADMINISTRATION SECTION

 Adults: 1-2 tablets 3 times per day or
as directed by a health practitioner. Not to exceed 6
tablets per 24 hours. Children under 18, as
directed by a health professional. Allow to
completely dissolve in the mouth

Active ingredients:

OTC - ACTIVE INGREDIENT SECTION

 Each 300 mg tablet contains:
*Apis mellifica 6X 30mg, Argentum nitricum 6X
30mg, *Belladonna 4X 30mg, *Cantharis 6X 30mg,
Causticum 8X 30mg, *Equisetum hyemale 6X 30mg,
*Petroselinum sativum 8X 30mg, *Pulsatilla 6X
30mg, *Sarsaparilla 6X 30mg, Terebinthina 8X 30mg.
*Natural

Inactive ingredients:

INACTIVE INGREDIENT SECTION

 *Dextrose, *Lactose,
Magnesium stearate, *Maltodextrin
*contains one or more of these ingredients

Purpose

OTC - PURPOSE SECTION

Urinary Pain Relief

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BHI Uri-Control.jpgBHI Uri-Control.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6cca4355-1206-91f7-02de-17eef38a8622Product name120140508
751c581a-bf64-2fd7-b3ec-ca02c83e4a00Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
62795-9004-22025-01-30C16284748780-12cef2736-b274-d83d-e063-dadaa90ab31fBHI Uri-Control

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62795-9004-2BHI Uri-Control1 in 1 CARTONTABLET12
62795-9004-2BHI Uri-Control100 in 1 BOTTLETABLET1002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62795-9004BHI URI-CONTROL (APIS MELLIFERA, SILVER NITRATE, ATROPA BELLADONNA, LYTTA VESICATORIA, CAUSTICUM, EQUISETUM HYEMALE, PETROSELINUM CRISPUM, PULSATILLA VULGARIS, SMILAX REGELII ROOT, AND TURPENTINE OIL) TABLET [MEDINATURA INC]2Legacy NDC, 2 package rows20230420_4d2184f0-30f3-4d8c-b51e-1a879be25640.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62795-9004-2EA - Each62795-9004ae0b4f1a-ef7f-49bf-8f43-428bf522c41512022-05-04

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62795-900462795-9004-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a9bfb09f-0839-4421-ad84-dc6ccc211a124d2184f0-30f3-4d8c-b51e-1a879be256402023-04-13WarningsExact identifier
spl id: a9bfb09f-0839-4421-ad84-dc6ccc211a12
spl set id: 4d2184f0-30f3-4d8c-b51e-1a879be25640

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.